Dr. Ryan J. Sullivan on Frontline Immunotherapy Sequencing in Melanoma

Source: Cancer Network, July 2019

Cancer Network spoke with Ryan J. Sullivan, MD, medical oncologist at Massachusetts General Hospital, about why immunotherapy sequencing rather than immunotherapy targeted therapy should be the frontline treatment for melanoma.